tocainide has been researched along with mexiletine in 87 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 65 (74.71) | 18.7374 |
1990's | 9 (10.34) | 18.2507 |
2000's | 11 (12.64) | 29.6817 |
2010's | 2 (2.30) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bódi, I; Frank, L; Hankovszky, OH; Hideg, K | 1 |
Topliss, JG; Yoshida, F | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Coumel, P; Krikler, D; Rosen, MR; Wellens, HJ; Zipes, DP | 1 |
Jung, W; Lüderitz, B; Manz, M | 1 |
Kwieciński, H; Ostrzycki, A; Ryniewicz, B | 1 |
Annesley, T; vasBinder, E | 1 |
Desai, DM; Gal, J; Meyer-Lehnert, S | 1 |
Roden, DM | 2 |
Podrid, PJ | 2 |
Lüderitz, B; Manz, M; Wagner, WL | 1 |
Graboys, TB; Grossbard, CL; Lown, B; Patt, MV | 1 |
Martinez, R; Swerdlow, CD | 1 |
Grauer, K; Gums, J; Skluth, H | 1 |
Barbey, JT; Echt, DS; Kopelman, HA; Murray, KT; Roden, DM; Siddoway, LA; Woosley, RL | 1 |
Snyder, DW | 1 |
Lampert, S; Lown, B; Podrid, PJ; Ravid, S | 1 |
Burchiel, KJ; Chabal, C; Russell, LC | 1 |
Somberg, J | 1 |
Roden, DM; Siddoway, LA; Woosley, RL | 1 |
Roy, D | 1 |
Blum, R; Hession, M; Lampert, S; Lown, B; Podrid, PJ; Stein, J | 1 |
Andersson, KE; Wettrell, G | 1 |
Morganroth, J; Nestico, PF | 2 |
Huang, SK; Marcus, FI | 1 |
Bernard, R; de Hemptinne, J; Gillet, JM; Lewinson, H; Liebens, I; Renard, M; Shita, A; Waterschoot, P | 1 |
Bauman, JL; Deal, BJ; Gallastegui, JL; Hariman, RJ; Martinez, JJ; Miller, SM; Scagliotti, D | 1 |
Horowitz, LN; Morganroth, J | 1 |
Di Biase, M; Favale, S; Rizzon, P; Visani, L | 1 |
Eigenberg, MC | 1 |
Easley, AR; Mann, DE; Reiter, MJ | 1 |
Hattori, Y; Ishihara, T; Kodama, I; Kusunoki, T; Toyama, J; Yamada, K | 1 |
Woosley, RL | 1 |
Hammill, SC; Kreeger, RW | 1 |
Linderer, EM; Tippe, A | 1 |
Hirosawa, K; Kasanuki, H; Onishi, S | 1 |
Collignon, P; Legrand, V | 1 |
Gupta, RN; Lew, M | 1 |
Fukuzaki, H; Itoh, S; Kobayashi, K | 1 |
Sanna, GP | 1 |
Lawrie, TD | 1 |
Almotrefi, AA; Baker, JB | 1 |
Schmitz, W | 1 |
Hillis, WS; Whiting, B | 1 |
Somberg, JC | 1 |
Doherty, JU; Josephson, ME; Kienzle, MG; Williams, PD; Zygmont, D | 1 |
Duff, HJ; Oates, JA; Roden, DM; Woosley, RL | 1 |
Mohiuddin, SM; Ross, WB | 1 |
Lüderitz, B | 1 |
Courtney, KR | 1 |
Rosen, MR; Wit, AL | 1 |
Block, PJ; Winkle, RA | 1 |
Pottage, A | 1 |
Colley, DG; Duff, HJ; Maffucci, R; Marney, S; Oates, JA; Primm, RK; Roden, DM; Woosley, RL | 1 |
Rossi, L | 1 |
Harrison, DC; Mead, RH | 1 |
Hellestrand, KJ | 1 |
Heger, JJ; Prystowsky, EN; Zipes, DP | 1 |
Luck, JC; Mann, DE; Pratt, CM; Wyndham, CR | 1 |
Ronfeld, RA | 1 |
Jewitt, DE | 1 |
Benchimol, A; Desser, KB | 1 |
Cho, YW; Kuemmerle, HP; Singh, BN | 1 |
Nademanee, K; Singh, BN | 1 |
Witkowska, M | 1 |
Mouselimis, N; Wester, HA | 1 |
Atallah, G; Kirkorian, G; Moleur, P; Touboul, P | 1 |
Benes, L; Cernusková, L; Csöllei, J; Svec, P; Tumová, I | 1 |
Jarvi, EJ; Loi, CM; Vestal, RE; Wei, X | 1 |
Conte Camerino, D; De Luca, A; Franchini, C; Lentini, G; Natuzzi, F; Tortorella, V | 1 |
Camerino, DC; De Luca, A; Duranti, A; Falcone, G; Franchini, C; Lentini, G; Natuzzi, F; Tortorella, V | 1 |
Dai, R; Friedman, FK; Thummel, KE; Vestal, RE; Wei, X; Zhai, S | 1 |
Mikó-Hideg, Z; Takács, M; Tóth, G; Vámos, J | 1 |
Kurihara, T; Nemoto, H | 1 |
Blackburn-Munro, G; Erichsen, HK; Hao, JX; Xu, XJ | 1 |
Camerino, DC; Corbo, F; De Luca, A; Desaphy, JF; Didonna, MP; Ferrannini, E; Franchini, C; Jockusch, H; Lentini, G; Liantonio, A; Natuzzi, F; Pierno, S; Tortorella, V | 1 |
Carr, DB; Challapalli, V; Lau, J; McNicol, ED; Tremont-Lukats, IW | 1 |
Carrieri, A; Corbo, F; Muraglia, M; Pacifico, C | 1 |
Carbonara, R; Carratù, MR; Conte Camerino, D; Corbo, F; De Bellis, M; De Luca, A; Desaphy, JF; Farinato, A; Franchini, C; Massari, A; Muraglia, M; Pierno, S; Roussel, J | 1 |
29 review(s) available for tocainide and mexiletine
Article | Year |
---|---|
The role of antiarrhythmic drugs in prevention of sudden cardiac death.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Death, Sudden; Disopyramide; Humans; Lidocaine; Mexiletine; Myocardial Infarction; Phenytoin; Procainamide; Quinidine; Random Allocation; Tocainide | 1985 |
Ventricular arrhythmias. An assessment of newer therapeutic agents.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Flecainide; Humans; Lidocaine; Mexiletine; Tocainide; United States | 1989 |
Class IB antiarrhythmic drugs: tocainide, mexiletine, and moricizine.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Tocainide | 1989 |
Antiarrhythmic drug therapy. Recent advances and current status.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Disopyramide; Drug Administration Schedule; Encainide; Flecainide; Heart Conduction System; Humans; Imidazoles; Lidocaine; Mexiletine; Moricizine; Myocardial Contraction; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tocainide; Verapamil | 1985 |
Clinical pharmacology of old and new antiarrhythmic drugs.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Benzeneacetamides; Biological Availability; Bretylium Compounds; Disopyramide; Encainide; Flecainide; Humans; Imipramine; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Tocainide | 1985 |
Antiarrhythmic drugs.
Topics: Action Potentials; Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Bretylium Compounds; Calcium Channel Blockers; Cell Membrane; Disopyramide; Electrophysiology; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Piperidines; Procainamide; Quinidine; Tocainide | 1986 |
Cardiovascular drugs. I: Antidysrhythmic drugs.
Topics: Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Cardiovascular Agents; Disopyramide; Drug Interactions; Humans; Kinetics; Lidocaine; Mexiletine; Phenytoin; Procainamide; Tocainide; Verapamil | 1986 |
Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment.
Topics: Aged; Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Digoxin; Disopyramide; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Piperidines; Procainamide; Propranolol; Quinidine; Tocainide; Verapamil | 1986 |
Antiarrhythmic drug therapy of ventricular arrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Sotalol; Tocainide; Verapamil | 1986 |
Antiarrhythmic agents for chronic ventricular arrhythmias.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Encainide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Procainamide; Propranolol; Quinidine; Tocainide | 1987 |
Class 1B agents lidocaine, mexiletine, tocainide, phenytoin.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Lidocaine; Mexiletine; Phenytoin; Tocainide | 1987 |
New antiarrhythmic drugs: tocainide, mexiletine, flecainide, encainide, and amiodarone.
Topics: Administration, Oral; Amiodarone; Anilides; Anti-Arrhythmia Agents; Drug Interactions; Encainide; Flecainide; Heart Conduction System; Humans; Lidocaine; Mexiletine; Tachycardia; Tocainide | 1987 |
Tocainide and mexiletine. Orally effective lidocaine analogues.
Topics: Administration, Oral; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Kinetics; Lidocaine; Mexiletine; Propylamines; Tocainide | 1985 |
Antiarrhythmic drug therapy (Part 2). Benefits and hazards.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Propafenone; Propiophenones; Tocainide | 1985 |
Comparison of newer antiarrhythmic agents.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Disopyramide; Humans; Mexiletine; Tocainide; Verapamil | 1980 |
[Electrophysiological classification of newer antiarrhythmic drugs (author's transl)].
Topics: Action Potentials; Adrenergic beta-Antagonists; Anilides; Animals; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Calcium; Disopyramide; Electrophysiology; Humans; Lidocaine; Mexiletine; Piperidines; Propafenone; Propiophenones; Quinidine; Sodium; Tocainide | 1980 |
Antiarrhythmic drug therapy for sustained ventricular tachycardia.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Bethanidine; Calcium Channel Blockers; Disopyramide; Drug Therapy, Combination; Electrocardiography; Electrophysiology; Encainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Phenytoin; Piperidines; Procainamide; Quinidine; Tachycardia; Tocainide | 1984 |
Electropharmacology of antiarrhythmic drugs.
Topics: Action Potentials; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disopyramide; Electric Conductivity; Heart Atria; Heart Ventricles; Humans; Lidocaine; Membrane Potentials; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Procainamide; Propranolol; Purkinje Fibers; Quinidine; Tocainide; Verapamil | 1983 |
Hemodynamic effects of antiarrhythmic drugs.
Topics: Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Benzeneacetamides; Bretylium Compounds; Calcium Channel Blockers; Disopyramide; Dose-Response Relationship, Drug; Encainide; Flecainide; Hemodynamics; Humans; Lidocaine; Mexiletine; Myocardial Contraction; Phenytoin; Piperidines; Procainamide; Quinidine; Tocainide | 1983 |
Clinical profiles of newer class I antiarrhythmic agents--tocainide, mexiletine, encainide, flecainide and lorcainide.
Topics: Administration, Oral; Anilides; Anti-Arrhythmia Agents; Benzeneacetamides; Dose-Response Relationship, Drug; Electrophysiology; Encainide; Flecainide; Hemodynamics; Humans; Injections, Intravenous; Kinetics; Lidocaine; Mexiletine; Piperidines; Tocainide | 1983 |
Therapy with investigational antiarrhythmic drugs.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Piperidines; Tocainide | 1984 |
Comparison of the efficacy of newly developed antiarrhythmic drugs in the treatment of ventricular tachyarrhythmias.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Coronary Disease; Encainide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Myocardial Infarction; Piperidines; Tachycardia; Tocainide; Ventricular Fibrillation | 1984 |
Investigational antiarrhythmic drugs for the treatment of ventricular rhythm disturbances.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Encainide; Flecainide; Humans; Imipramine; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Tocainide | 1984 |
Comparative pharmacokinetics of new antiarrhythmic drugs.
Topics: Anilides; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Disopyramide; Humans; Kinetics; Mexiletine; Piperidines; Tocainide; Verapamil | 1980 |
Hemodynamic effects of newer antiarrhythmic drugs.
Topics: Acebutolol; Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Atenolol; Benzeneacetamides; Disopyramide; Dogs; Hemodynamics; Humans; Mexiletine; Piperidines; Tocainide; Verapamil | 1980 |
[Clinical pharmacology of anti-arrhythymia agents. II. Lignocaine, mexiletine, tocainide, phenytoin].
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Kinetics; Lidocaine; Mexiletine; Tocainide | 1981 |
[New antiarrythmic drugs: mexiletine, tocainide, lorcainide, encainide, flecainide, propafenone, cipralan, sotalol].
Topics: Anilides; Animals; Anti-Arrhythmia Agents; Benzeneacetamides; Electrophysiology; Encainide; Flecainide; Hemodynamics; Humans; Imidazoles; Lidocaine; Mexiletine; Piperidines; Propafenone; Propiophenones; Sotalol; Tocainide | 1982 |
[Na channel myotonia].
Topics: Chromosomes, Human, Pair 7; Diagnosis, Differential; Exons; Genes, Dominant; Humans; Mexiletine; Mutation; Myotonia; Prognosis; Sodium Channel Blockers; Sodium Channels; Tocainide | 2001 |
Systemic administration of local anesthetic agents to relieve neuropathic pain.
Topics: Administration, Oral; Anesthetics, Intravenous; Anesthetics, Local; Flecainide; Humans; Lidocaine; Mexiletine; Nervous System Diseases; Pain; Randomized Controlled Trials as Topic; Tocainide | 2005 |
7 trial(s) available for tocainide and mexiletine
Article | Year |
---|---|
Treatment of myotonia with antiarrhythmic drugs.
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Disopyramide; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography; Female; Humans; Male; Mexiletine; Middle Aged; Myotonia; Myotonia Congenita; Myotonic Dystrophy; Neurologic Examination; Phenytoin; Prospective Studies; Single-Blind Method; Tocainide | 1992 |
The role of antiarrhythmic drugs in prevention of sudden cardiac death.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Death, Sudden; Disopyramide; Humans; Lidocaine; Mexiletine; Myocardial Infarction; Phenytoin; Procainamide; Quinidine; Random Allocation; Tocainide | 1985 |
[Combination of sotalol with the class I B substances mexiletine or tocainide in complex ventricular extrasystole].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Drug Therapy, Combination; Electrocardiography; Female; Heart Ventricles; Humans; Lidocaine; Male; Mexiletine; Middle Aged; Sotalol; Tocainide | 1987 |
Mexiletine and tocainide: a comparison of antiarrhythmic efficacy, adverse effects, and predictive value of lidocaine testing.
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Drug Evaluation; Drug Resistance; Drug Therapy, Combination; Electric Stimulation; Female; Heart Ventricles; Humans; Lidocaine; Male; Mexiletine; Middle Aged; Prospective Studies; Quinidine; Random Allocation; Tocainide | 1989 |
Electrophysiologic testing of tocainide and mexiletine for ventricular tachycardia: assessment of the need to test both drugs.
Topics: Drug Evaluation; Heart Ventricles; Humans; Lidocaine; Mexiletine; Prospective Studies; Tachycardia; Tocainide | 1986 |
Selection of an antiarrhythmic drug for a sudden-death-prevention trial.
Topics: Acecainide; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bretylium Compounds; Clinical Trials as Topic; Death, Sudden; Encainide; Flecainide; Humans; Kinetics; Lidocaine; Mexiletine; Moricizine; Morpholines; Phenothiazines; Piperidines; Tocainide; Verapamil | 1982 |
[The effect of anti-arrhythmic drugs on myocardial function (author's transl)].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Coronary Disease; Depression, Chemical; Disopyramide; Echocardiography; Humans; Lidocaine; Mexiletine; Middle Aged; Myocardial Contraction; Placebos; Propafenone; Propiophenones; Tocainide | 1982 |
52 other study(ies) available for tocainide and mexiletine
Article | Year |
---|---|
New antiarrhythmic agents. 2,2,5,5-Tetramethyl-3-pyrroline-3-carboxamides and 2,2,5,5-tetramethylpyrrolidine-3-carboxamindes.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Evaluation, Preclinical; Indicators and Reagents; Magnetic Resonance Spectroscopy; Nicotine; Ouabain; Rats; Spectrophotometry, Infrared; Structure-Activity Relationship | 1986 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Newer antiarrhythmic drugs.
Topics: Administration, Oral; Adult; Amiodarone; Animals; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Child; Edrophonium; Electrophysiology; Heart Conduction System; Heart Ventricles; Humans; Injections, Intravenous; Lidocaine; Mexiletine; Recurrence; Tachycardia; Tocainide; Verapamil; Wolff-Parkinson-White Syndrome | 1978 |
[Combination anti-arrhythmic drug therapy].
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Drug Therapy, Combination; Electrocardiography, Ambulatory; Encainide; Flecainide; Humans; Mexiletine; Sotalol; Tachycardia; Tocainide | 1992 |
Liquid chromatographic analysis of mexiletine in serum, with alternate application to tocainide, procainamide, and N-acetylprocainamide.
Topics: Acecainide; Chromatography, High Pressure Liquid; Humans; Lidocaine; Mexiletine; Procainamide; Tocainide | 1991 |
Reversed-phase LC resolutions of chiral antiarrhythmic agents via derivatization with homochiral isothiocyanates.
Topics: Anti-Arrhythmia Agents; Chromatography, Liquid; Flecainide; Humans; Indicators and Reagents; Lidocaine; Male; Mexiletine; Propafenone; Thiocyanates; Tocainide | 1990 |
Antiarrhythmic drugs. Clinical pharmacology of the old and the new agents.
Topics: Acecainide; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden; Delayed-Action Preparations; Disopyramide; Heart Arrest; Humans; Lidocaine; Mexiletine; Myocardial Infarction; Procainamide; Resuscitation; Tocainide | 1985 |
Combination antiarrhythmic therapy for management of malignant ventricular arrhythmia.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Drug Therapy, Combination; Electrocardiography; Exercise Test; Female; Humans; Lidocaine; Male; Mexiletine; Middle Aged; Monitoring, Physiologic; Quinidine; Tachycardia; Tocainide | 1988 |
Lidocaine & tocainide & mexiletine.
Topics: Drug Interactions; Humans; Lidocaine; Mexiletine; Tocainide | 1989 |
Congestive heart failure induced by six of the newer antiarrhythmic drugs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anilides; Anti-Arrhythmia Agents; Benzeneacetamides; Encainide; Female; Heart Failure; Humans; Lidocaine; Male; Mexiletine; Middle Aged; Moricizine; Phenothiazines; Piperidines; Propafenone; Risk Factors; Stroke Volume; Tocainide | 1989 |
The effect of intravenous lidocaine, tocainide, and mexiletine on spontaneously active fibers originating in rat sciatic neuromas.
Topics: Action Potentials; Animals; Dose-Response Relationship, Drug; Injections, Intravenous; Lidocaine; Male; Mexiletine; Neural Conduction; Neuroma; Rats; Rats, Inbred Strains; Sciatic Nerve; Stress, Mechanical; Tocainide | 1989 |
Mexiletine and tocainide: does response to one predict response to the other?
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electric Stimulation; Electrocardiography; Female; Heart Ventricles; Humans; Lidocaine; Male; Mexiletine; Middle Aged; Propylamines; Stroke Volume; Tachycardia; Tocainide; Ventricular Fibrillation | 1986 |
[Hemodynamic repercussions and clinical tolerance of 6 class I anti-arrhythmia agents in acute myocardial infarction].
Topics: Ajmaline; Anti-Arrhythmia Agents; Benzeneacetamides; Fluorenes; Hemodynamics; Lidocaine; Mexiletine; Myocardial Infarction; Piperidines; Tocainide | 1986 |
Second generation antiarrhythmic agents: have we reached antiarrhythmic Nirvana?
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Tocainide | 1987 |
Mexitil and cross-allergenicity.
Topics: Cross Reactions; Humans; Lidocaine; Mexiletine; Tocainide | 1987 |
Efficacy of class Ib (lidocaine-like) antiarrhythmic agents for prevention of sustained ventricular tachycardia secondary to coronary artery disease.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Coronary Disease; Electrophysiology; Female; Heart Ventricles; Humans; Lidocaine; Male; Mexiletine; Middle Aged; Procainamide; Tachycardia; Tocainide; Ventricular Fibrillation | 1987 |
Use-dependent blocking action of newly developed lidocaine-analogs on maximum rate of rise of action potentials in guinea pig papillary muscle.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Depression, Chemical; Guinea Pigs; Kinetics; Lidocaine; Mexiletine; Papillary Muscles; Structure-Activity Relationship; Tocainide | 1987 |
Mexiletine and tocainide: a profile of two lidocaine analogs.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrophysiology; Heart; Humans; In Vitro Techniques; Lidocaine; Mexiletine; Tocainide | 1987 |
Action of tocainide and mexiletine on the excitation threshold of myelinated nerves.
Topics: Action Potentials; Animals; Electrophysiology; In Vitro Techniques; Lidocaine; Membrane Potentials; Mexiletine; Myelin Sheath; Nerve Fibers; Rana esculenta; Sodium; Tocainide | 1987 |
The usefulness of electrophysiological-pharmacologic studies in the long-term therapy of paroxysmal tachycardias.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Cardiomyopathies; Chromatography, High Pressure Liquid; Disopyramide; Electric Stimulation; Electrocardiography; Female; Humans; Lidocaine; Male; Mexiletine; Middle Aged; Myocardial Infarction; Propafenone; Propiophenones; Quinidine; Tachycardia, Paroxysmal; Time Factors; Tocainide; Verapamil | 1985 |
Haemodynamic effects of class I antiarrhythmic agents.
Topics: Anti-Arrhythmia Agents; Disopyramide; Flecainide; Hemodynamics; Humans; Lidocaine; Mexiletine; Piperidines; Procainamide; Quinidine; Tocainide | 1985 |
Liquid chromatographic determination of mexiletine and tocainide in human plasma with fluorescence detection after reaction with a modified o-phthalaldehyde reagent.
Topics: Chromatography, Liquid; Drug Stability; Humans; Lidocaine; Mexiletine; o-Phthalaldehyde; Propylamines; Spectrometry, Fluorescence; Tocainide | 1985 |
[Anti-arrhythmia agents (II): Mexiletine, aprindine, tocainide and amiodarone].
Topics: Action Potentials; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Humans; Lidocaine; Mexiletine; Tocainide | 1985 |
New drugs in the management of ventricular arrhythmias.
Topics: Acecainide; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bretylium Compounds; Drug Interactions; Encainide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Propafenone; Propiophenones; Tocainide | 1984 |
The antifibrillatory potency of aprindine, mexiletine, tocainide and lignocaine compared on Langendorff-perfused hearts of rabbits and guinea-pigs.
Topics: Anilides; Animals; Anti-Arrhythmia Agents; Aprindine; Dose-Response Relationship, Drug; Female; Guinea Pigs; Heart; In Vitro Techniques; Indenes; Lidocaine; Male; Mexiletine; Ouabain; Perfusion; Propylamines; Rabbits; Tocainide; Ventricular Fibrillation | 1980 |
Antiarrhythmic drugs.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Disopyramide; Flecainide; Humans; Kinetics; Lidocaine; Mexiletine; Piperidines; Procainamide; Quinidine; Tocainide; Verapamil | 1983 |
New directions in antiarrhythmic drug therapy.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Death, Sudden; Disopyramide; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tachycardia; Tocainide; Verapamil | 1984 |
Antiarrhythmic therapy: new additions and future expectations.
Topics: Acecainide; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Bretylium Tosylate; Disopyramide; Encainide; Humans; Lidocaine; Mexiletine; Tocainide; Verapamil | 1983 |
[Drug therapy of arrhythmia in coronary cardiopathy].
Topics: Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Cardiac Complexes, Premature; Coronary Disease; Disopyramide; Electrocardiography; Humans; Lidocaine; Mexiletine; Piperidines; Propafenone; Propiophenones; Tachycardia; Tocainide | 1983 |
Depressant effects of drugs used in myotonia therapy.
Topics: Animals; In Vitro Techniques; Ion Channels; Lidocaine; Mexiletine; Muscle Contraction; Myotonia; Phenytoin; Procainamide; Quinidine; Rana catesbeiana; Tocainide | 1982 |
Molecular basis for the antigenicity of lidocaine analogs: tocainide and mexiletine.
Topics: Aged; Anti-Arrhythmia Agents; Antigens; Cross Reactions; Drug Hypersensitivity; Female; Humans; Intradermal Tests; Lidocaine; Mexiletine; Propylamines; Structure-Activity Relationship; Tocainide | 1984 |
Nursing care for survivors of sudden cardiac death.
Topics: Adaptation, Psychological; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Heart Arrest; Heart Conduction System; Humans; Lidocaine; Mexiletine; Moricizine; Nursing Assessment; Phenothiazines; Tocainide | 1984 |
Drug therapy of cardiac arrhythmias.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Biological Availability; Encainide; Half-Life; Humans; Imidazoles; Intestinal Absorption; Kinetics; Lidocaine; Metabolic Clearance Rate; Mexiletine; Propafenone; Propiophenones; Protein Binding; Tachycardia; Tocainide | 1983 |
New drugs for treating cardiac arrhythmias.
Topics: Acebutolol; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Encainide; Heart Ventricles; Humans; Mexiletine; Moricizine; Morpholines; Phenothiazines; Tocainide; Verapamil | 1981 |
Clinical pharmacology of antiarrhythmic drugs: a review and overview, part II.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disopyramide; Humans; Kinetics; Lidocaine; Mexiletine; Phenytoin; Procainamide; Propranolol; Tocainide | 1981 |
Advances in antiarrhythmic therapy. The role of newer antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Atrioventricular Node; Humans; Lidocaine; Mexiletine; Tocainide; Verapamil | 1982 |
Tocainide--an alternative to mexiletine.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Lidocaine; Mexiletine; Tocainide | 1982 |
Carbamate analogues of tocainide.
Topics: Aconitine; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Carbamates; Cardiac Complexes, Premature; Epinephrine; Guinea Pigs; Mexiletine; Ouabain; Rats; Tocainide | 1994 |
Relative potency of mexiletine, lidocaine, and tocainide as inhibitors of rat liver CYP1A1 activity.
Topics: Animals; Anti-Arrhythmia Agents; Cytochrome P-450 CYP1A1; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Induction; Enzyme Inhibitors; Immunoblotting; In Vitro Techniques; Kinetics; Lidocaine; Male; Mexiletine; Microsomes, Liver; Oxidoreductases; Rats; Rats, Sprague-Dawley; Tocainide | 1995 |
Stereoselective effects of mexiletine enantiomers on sodium currents and excitability characteristics of adult skeletal muscle fibers.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; Mexiletine; Muscle, Skeletal; Patch-Clamp Techniques; Rana esculenta; Sodium Channels; Stereoisomerism; Tocainide | 1995 |
Inhibition of frog skeletal muscle sodium channels by newly synthesized chiral derivatives of mexiletine and tocainide.
Topics: Animals; Anti-Arrhythmia Agents; Mexiletine; Muscle, Skeletal; Patch-Clamp Techniques; Rana esculenta; Sodium Channel Blockers; Stereoisomerism; Tocainide | 1997 |
Inhibition of human liver cytochrome P-450 1A2 by the class IB antiarrhythmics mexiletine, lidocaine, and tocainide.
Topics: Anti-Arrhythmia Agents; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Humans; Immunoblotting; In Vitro Techniques; Kinetics; Lidocaine; Mexiletine; Models, Molecular; Oxidoreductases; Tocainide | 1999 |
Photochemical and chemical oxidation of mexiletine and tocainide. Structure elucidation of the major products.
Topics: Anti-Arrhythmia Agents; Magnetic Resonance Spectroscopy; Mexiletine; Oxidation-Reduction; Photochemistry; Tocainide | 2000 |
A comparison of the antinociceptive effects of voltage-activated Na+ channel blockers in two rat models of neuropathic pain.
Topics: Analgesics; Analysis of Variance; Anesthetics, Local; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Hindlimb; Lamotrigine; Lidocaine; Male; Mexiletine; Neuralgia; Pain Measurement; Rats; Rats, Sprague-Dawley; Sodium Channel Blockers; Sodium Channels; Time Factors; Tocainide; Triazines | 2003 |
New potent mexiletine and tocainide analogues evaluated in vivo and in vitro as antimyotonic agents on the myotonic ADR mouse.
Topics: Action Potentials; Analysis of Variance; Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Electric Conductivity; Electromyography; Female; In Vitro Techniques; Inhibitory Concentration 50; Male; Mexiletine; Mice; Mice, Mutant Strains; Muscle Contraction; Myotonic Disorders; Patch-Clamp Techniques; Sodium Channels; Structure-Activity Relationship; Time Factors; Tocainide | 2004 |
2D- and 3D-QSAR of tocainide and mexiletine analogues acting as Na(v)1.4 channel blockers.
Topics: Crystallography, X-Ray; Mexiletine; Protein Isoforms; Quantitative Structure-Activity Relationship; Sodium Channel Blockers; Sodium Channels; Substrate Specificity; Tocainide | 2009 |
Increased sodium channel use-dependent inhibition by a new potent analogue of tocainide greatly enhances in vivo antimyotonic activity.
Topics: Animals; Dose-Response Relationship, Drug; Ether-A-Go-Go Potassium Channels; Humans; Male; Mexiletine; Muscle, Skeletal; Myotonia; NAV1.4 Voltage-Gated Sodium Channel; Rats; Rats, Wistar; Reflex, Righting; Rotarod Performance Test; Tocainide; Voltage-Gated Sodium Channel Blockers | 2017 |